Advertisement

Measurement of Radioligand Binding by Scintillation Proximity Assay

  • Jenny Berry
  • Molly Price-Jones
Protocol
Part of the Methods in Molecular Biology™ book series (MIMB, volume 306)

Abstract

Scintillation proximity assay (SPA) is a homogeneous assay technology (1) which is bead-based and removes the need for a filtration step to separate bound from free ligand in a receptor-binding assay. The principle of the technology is shown in Fig. 1 .

Keywords

Amersham Bioscience Assay Buffer Wheat Germ Agglutinin Soluble Receptor Copper Chelate 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Bosworth, N and Towers, P. (1989) Scintillation Proximity Assay. Nature 341, 167–168.PubMedCrossRefGoogle Scholar
  2. 4.
    Berry, J. A., Burgess, A. J., and Towers, P. (1991) Scintillation Proximity assay; competitive binding studies with [125I]endothelin-1 in human placenta and porcine lung. J. Cardiovasc. Pharmacol. 17 (Suppl 7), S143–S145.PubMedCrossRefGoogle Scholar
  3. 5.
    Anon. Biotinylation Techniques and their use in Developing Scintillation Proximity Assays. Proximity News 39, Amersham Biosciences. Available from: http://www4.amershambiosciences.com/aptrix/upp00919.nsf/Content/WD%3AProximity+News+%28148896178-B345%29?OpenDocument&hometitle=DrugScr [Accessed 27 Feb 2004].
  4. 6.
    Anon. SPA Cytokine Receptor Binding assays. Proximity News 37, Amersham Biosciences. Available from: http://www4.amershambiosciences.com/aptrix/upp00919.nsf/Content/WD%3AProximity+News+%28148896913-B345%29?OpenDocument&hometitle=DrugScr [Accessed 27 Feb 2004].
  5. 7.
    Urban, F., Jr., Cavazos, G., Dunbar, J., et al. (2000) The important role of residue F268 in ligand binding by LXR. FEBS Lett. 484, 159–163.PubMedCrossRefGoogle Scholar
  6. 8.
    Anon. Selection of SPA bead type for receptor Scintillation Proximity Assays. Proximity News 54, Amersham Biosciences. Available from: http://www4.amershambiosciences.com/aptrix/upp00919.nsf/Content/WD%3AProximity+News+% 28148897012-B345%29?OpenDocument&hometitle=DrugScr [Accessed 27 Feb 2004].
  7. 9.
    Anon. Kinetics of inhibition of receptor binding measured by Scintillation Proximity Assay. Proximity News 14, Amersham Biosciences. Available from: http://www4.amershambiosciences.com/aptrix/upp00919.nsf/Content/WD%3AProximity+ News+%28183972869-R165%29?OpenDocument& hometitle=DrugScr [Accessed 27 Feb 2004].
  8. 10.
    Anon. Characterisation of D-myo-[3H]Inositol 1,4,5 Trisphosphate binding topurified Inositol Trisphosphate Receptors by Scintillation Proximity Assay. Proximity News 12, Amersham Biosciences. Available from: http://www4.amershambiosciences.com/aptrix/upp00919.nsf/Content/WD%3AProximity+News+% 28183698040-R165%29?OpenDocument&hometitle=DrugScr [Accessed 27 Feb 2004].
  9. 11.
    Patel, S., Harris, A, O’Beirne, G., et al. (1995) Characterisation of inositol 1,4,5 trisphosphate binding by scintillation proximity assay. Br. J. of Pharmacol.,115, Proceedings supplement, July 35P.Google Scholar

Copyright information

© Humana Press Inc. 2005

Authors and Affiliations

  • Jenny Berry
    • 1
  • Molly Price-Jones
    • 1
  1. 1.The Maynard Centre, GE Healthcare BiosciencesCardiffUK

Personalised recommendations